HealthRX.com · Printable appeal checklist
Blue Cross NC Wegovy request and North Carolina external review packet
Pin down your plan type and whether it carries anti-obesity medication benefits, gather what the July 2026 Blue Cross NC policy asks the prescriber to show, log weight through the lifestyle period, and track the state external review clock if the final appeal is denied.
Your plan
Plan name, group number and member ID
Plan typefully insured group, self-funded employer, individual, State Health Plan, Medicare Advantage
Does the plan include anti-obesity medication benefits? Who confirmed it, and when?
Is Wegovy on your formulary, or non-formulary?
What the prescriber's request should show
- Obesity diagnosis and a measured BMI, with the date
- Weight-related conditions, if BMI is 27 to under 30
- Ancestry noted, if the request relies on the BMI 25 route for South Asian, Southeast Asian or East Asian descent
- For heart-risk use: the past heart attack, stroke or peripheral artery disease, and current heart medicines
- For MASH: the fibrosis stage, the test that confirmed it, and the liver specialist who prescribed or was consulted
- No other GLP-1 or weight-loss medicine at the same time
- The lifestyle plan during treatment, and the 6-month lifestyle record or the condition that needs medicine now
Weight during the lifestyle period
The policy defines acceptable lifestyle weight loss as 1 lb a week over a 6-month period.
| Date | Weight | Pounds lost since the start | What you were doing (diet, activity, program) |
|---|---|---|---|
From Blue Cross NC's July 2026 policy
- Coverage under this policy requires anti-obesity medication benefits in the member's plan.[1]
- When the member's formulary excludes Wegovy, non-formulary exception criteria apply as well.[1]
- A first approval lasts 180 days; a continuation lasts 365 days.[1]
- For weight management, continuation needs at least 5% weight loss from the pre-treatment baseline, kept off.[1]
- The 0.25 mg, 0.5 mg and 1 mg pens are limited to 4 pens per 28 days.[1]
- A criterion about previous weight-loss medication trials was removed in April 2023.[1]
North Carolina external review
- It is free, and it is for denials of medically necessary treatment.[2]
- File within 120 days of the insurer's final appeal decision.[2]
- Smart NC says within 10 business days whether a standard request is complete and accepted; the decision follows within 45 days of the request.[2]
- Self-funded employer plans are outside the state process.[2]
- The reviewer's decision binds you and the health plan.[2]
If you have Medicare drug coverage
- Medicare's GLP-1 Bridge has covered Wegovy injection or tablets for eligible people since July 1, 2026, at $50 for a one-month supply.[3]
Request, appeal and review dates
| Date | Step (request, denial, appeal, external review) | Reference number | Deadline that follows |
|---|---|---|---|
Questions for Blue Cross NC
- Does my plan include anti-obesity medication benefits, and is it fully insured or self-funded?
- Is Wegovy on my formulary, or would it need a non-formulary exception?
- Which use was the request reviewed under: weight management, heart risk or MASH?
- Which criterion did the denial say was not met?
- When does my approval end, and what weight will the continuation request compare with my baseline?
- Where should the internal appeal be sent, and when is the final appeal decision due?
Sources for the facts on this sheet
- Blue Cross and Blue Shield of North Carolina. Utilization Management Policy: Anti-Obesity Agents – NC Standard (July 2026). Accessed 2026-10-19. https://www.bcbsnc.com/content/dam/bcbsnc/pdf/providers/policies-guidelines-codes/commercial/um/pharmacy-benefit/updates/anti-obesity-agents-nc-standard.pdf
- North Carolina Department of Insurance. Request an External Review | NC DOI. Accessed 2026-10-19. https://www.ncdoi.gov/consumers/health-insurance/health-claim-denied/request-external-review
- Centers for Medicare & Medicaid Services, Medicare.gov. Weight loss drugs | Medicare. Accessed 2026-10-19. https://www.medicare.gov/coverage/weight-loss-drugs
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.